Printer Friendly

Neogen Corporation, Lansing, MI, announces it has completed the acquisition of Brussels, Belgium-based UCB's dairy antibiotic testing business.

Neogen Corporation, Lansing, MI, announces it has completed the acquisition of Brussels, Belgium-based UCB's dairy antibiotic testing business. Neogen will assume the operations of UCB's former antibiotic testing business effective immediately.

The business will continue to operate in the current facilities in Spain for approximately 60 days. After that time, Neogen will begin integrating the manufacture of the diagnostic test kits into existing operations in the United States. Sales of the former UCB products within North America will be handled by existing Neogen sales personnel. Sales outside of North America will continue to be handled by Chr. Hansen, a worldwide supplier of products to the dairy processing industry.
COPYRIGHT 2006 Doane Information Service
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:COMPANY NEWS
Publication:Agri Marketing
Article Type:Brief Article
Geographic Code:1USA
Date:Jan 1, 2006
Words:108
Previous Article:Syngenta Seeds.
Next Article:Deere & Co., Moline, IL, has agreed to sell its wholly-owned managed care subsidiary to UnitedHealthcare of Minneapolis.
Topics:


Related Articles
UCB.
3M acquires Hoechst AG's interest in Dyneon.
Clarification.
Neogen Corporation, Lansing, Mich., has acquired Hacco Inc. and Hess & Clark Inc., both wholly owned companies of United Agri Products, a subsidiary...
UCB LICENSES SEPRACOR U.S. PATENTS FOR ANTIHISTAMINE.
UCB SELLS OTC DELSYM TO ADAMS RESPIRATORY THERAPEUTICS.
UCB GETS POSITIVE RESULTS FROM TWO CIMIZIA PHASE III STUDIES.

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters